Dr. Berlin received his doctorate in biostatistics from the Harvard School of Public Health in 1988. After spending 15 years as a faculty member at the University of Pennsylvania, in the Center for Clinical Epidemiology and Biostatistics, under the direction of Dr. Brian Strom, Jesse left Penn to join Janssen Research & Development, as a Senior Director in Biostatistics. After 2 years, he was promoted to Vice President for Epidemiology. He now serves as Vice President of Epidemiology across all of Johnson & Johnson, with responsibility for pharmaceuticals, devices and consumer products. He has authored or coauthored over 250 peer-reviewed publications in a wide variety of clinical and methodological areas, including papers on the study of meta-analytic methods as applied to both randomized trials and epidemiology. He served on an Institute of Medicine Committee that developed recently-released recommendations for the use of systematic reviews in clinical effectiveness research, and currently serves as Chair of the Scientific Advisory Committee to IMEDS (Innovation in Medical Evidence Development and Surveillance), part of the Reagan-Udall Foundation. IMEDS is aimed at understanding methodology for assessing drug safety in large, administrative databases. Dr. Berlin co-chairs the Scientific Oversight Committee (with Greg Pappas from FDA) for MDEpiNet, a public-private partnership which is working toward developing methods and data sources for the evaluation of medical devices. He also serves on the Executive Operations Committee for MDEpiNet. Dr. Berlin serves as a member of working group X for CIOMS (The Council for International Organizations of Medical Sciences), which is developing guidelines for meta-analysis of drug safety data in the regulatory context. He was elected as a fellow of the American Statistical Association in 2004. In 2013, Dr. Berlin received the Lagakos Distinguished Alumni Award from the Department of Biostatistics at the Harvard School of Public Health.